The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may well result in an increase in oxycodone plasma concentrations, which could boost or prolong adverse reactions and will result in perhaps lethal respiratory despair. In addition, discontinuation of a concomitantly utilized cytochrome P450 3A4 inducer could lead to an